Reply

Affiliations

¹ Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York; Weill-Cornell Medical Center, New York, New York. Electronic address: francij1@mskcc.org.
² Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York; Weill-Cornell Medical Center, New York, New York.
³ Jules-Gonin Eye Hospital, Lausanne, Switzerland.
⁴ Pediatric Hematology Oncology Unit, University Hospital, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Comment

Jasmine H Francis et al. Ophthalmology. 2016 Feb.

. 2016 Feb;123(2):e10-e11.

doi: 10.1016/j.ophtha.2015.07.015.

¹ Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York; Weill-Cornell Medical Center, New York, New York. Electronic address: francij1@mskcc.org.
² Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York; Weill-Cornell Medical Center, New York, New York.
³ Jules-Gonin Eye Hospital, Lausanne, Switzerland.
⁴ Pediatric Hematology Oncology Unit, University Hospital, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

No abstract available

Comment on

The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.
Francis JH, Abramson DH, Gaillard MC, Marr BP, Beck-Popovic M, Munier FL. Francis JH, et al. Ophthalmology. 2015 Jun;122(6):1173-9. doi: 10.1016/j.ophtha.2015.01.017. Epub 2015 Mar 18. Ophthalmology. 2015. PMID: 25795478
Re: Francis et al.: The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan (Ophthalmology 2015;122:1173-9).
Sahoo N, Tripathy D. Sahoo N, et al. Ophthalmology. 2016 Feb;123(2):e10. doi: 10.1016/j.ophtha.2015.06.054. Ophthalmology. 2016. PMID: 26802711 No abstract available.